Abstract
Background The aim of the study was to establish syndromic diagnoses in patients presenting with respiratory symptoms to healthcare facilities in Vietnam and to compare the diagnoses with the facility-level clinical diagnoses and treatment decisions.
Methods A representative sample of patients, aged≥5 years, presenting with dyspnoea, cough, wheezing, and/or chest tightness to health facilities in four provinces of Vietnam were systematically evaluated. Eight common syndromes were defined using data obtained.
Results We enrolled 977 subjects at 39 facilities. We identified fixed airflow limitation (FAL) in 198 (20.3%) patients and reversible airflow limitation (RAL) in 26 (2.7%) patients. Patients meeting the criteria for upper respiratory tract infection (URTI) alone constituted 160 (16.4%) patients and 470 (48.1%) did not meet the criteria for any of the syndromes. Less than half of patients with FAL were given long-acting bronchodilators. A minority of patients with either RAL or FAL with eosinophilia were prescribed inhaled corticosteroids. Antibiotics were given to more than half of all patients, even among those with URTI alone.
Conclusion This study identified a substantial discordance between prescribed treatment, clinician diagnosis and a standardised syndromic diagnosis among patients presenting with respiratory symptoms. Increased access to spirometry and implementation of locally-relevant syndromic approaches to management may help to improve patient care in resource-limited settings.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Dr. Huang has nothing to disclose.
Conflict of interest: Dr. Fox has nothing to disclose.
Conflict of interest: Dr. Pham has nothing to disclose.
Conflict of interest: Dr. Nguyen has nothing to disclose.
Conflict of interest: Dr. VU VAN has nothing to disclose.
Conflict of interest: Dr. NGO QUY has nothing to disclose.
Conflict of interest: Dr. Nguyen V. has nothing to disclose.
Conflict of interest: Dr. Jan has nothing to disclose.
Conflict of interest: Dr. Negin reports grants from Global Alliance for Chronic Diseases, during the conduct of the study;.
Conflict of interest: Dr. Le Thi Tuyet has nothing to disclose.
Conflict of interest: G.B. Marks reports funds for research paid to his institution by and participation in a expert panel for AstraZeneca, and funds for research paid to his institution by GSK, outside the submitted work.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received August 12, 2020.
- Accepted November 5, 2020.
- Copyright ©ERS 2020
This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.